Tone mix
Week by week 52 weeks
Share of Amylyx Pharmaceuticals, Inc. Common Stock's 108 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Dec 22, 2025 · tone -100Stock Analysts' Downgrades for December 20th (ACR, ACXP, AFYA, AGYS, AIR, ALGT, AMLX, APTV, AREC, ATMU)-106
- Week of Apr 6, 2026 · tone -54Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?-94
- Week of Jan 12, 2026 · tone +98Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases+92
- Week of Oct 19, 2026 · tone +100Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $39.00+60
- Week of Mar 23, 2026 · tone +100Amylyx Pharmaceuticals (NASDAQ:AMLX) Receives "Buy" Rating from HC Wainwright+59
- Week of Oct 5, 2026 · tone 0Insider Selling: Amylyx Pharmaceuticals (NASDAQ:AMLX) Director Sells 30,000 Shares of Stock-59
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Amylyx Pharmaceuticals, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 3 | +33 |
| Last 90 sessions | 34 | +48 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 19, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletAmylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $39.00Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $39.00 | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 8, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletInsider Selling: Amylyx Pharmaceuticals (NASDAQ:AMLX) Director Sells 30,000 Shares of StockNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Insider Selling: Amylyx Pharmaceuticals (NASDAQ:AMLX) Director Sells 30,000 Shares of Stock | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 1, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHead-To-Head Contrast: Amylyx Pharmaceuticals (NASDAQ:AMLX) & Taysha Gene Therapies (NASDAQ:TSHA)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Contrast: Amylyx Pharmaceuticals (NASDAQ:AMLX) & Taysha Gene Therapies (NASDAQ:TSHA) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, September 16, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletContrasting Amylyx Pharmaceuticals (NASDAQ:AMLX) and Protalix BioTherapeutics (NYSE:PLX)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Contrasting Amylyx Pharmaceuticals (NASDAQ:AMLX) and Protalix BioTherapeutics (NYSE:PLX) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, August 31, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletAmylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $57.00Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $57.00 | www.themarketsdaily.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Amylyx Pharmaceuticals, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.